AI Article Synopsis

  • The study investigated the anticancer effects of sweet cherry extract on human prostate cells, focusing on different cherry cultivars from Fundão, Portugal.
  • The Saco "late harvest" extract, rich in anthocyanins, was used in biological assays on both non-neoplastic (PNT1A) and neoplastic (LNCaP and PC3) prostate cells.
  • Results showed that the cherry extract reduced cell viability in both types of cells, increased apoptosis particularly in LNCaP cells, and decreased oxidative damage and glycolytic metabolism in the neoplastic cells.

Article Abstract

The present work evaluated the anticancer properties of sweet cherry () extract on human prostate cells. Several sweet cherry cultivars from Fundão (Portugal) were methanol-extracted and their phytochemical composition characterized. The Saco "late harvest" extract was highly-enriched in anthocyanins and selected for use in biological assays. Non-neoplastic (PNT1A) and neoplastic (LNCaP and PC3) human prostate cells were treated with 0-2,000 μg/ml of extract for 48-96 h. Cell viability was evaluated by the MTT assay. Apoptosis, oxidative stress, and glycolytic metabolism were assessed by Western blotting and enzymatic assays. Glucose consumption and lactate production were measured spectrophotometrically. Saco cherry extract diminished the viability of neoplastic and non-neoplastic cells, whereas enhancing apoptosis in LNCaP. Cherry extract-treatment also diminished oxidative damage and suppressed glycolytic metabolism in LNCaP cells. These findings widened the knowledge on the mechanisms by which cherry extract modulate cell physiology, demonstrating their broad action over the hallmarks of cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1080/01635581.2019.1661502DOI Listing

Publication Analysis

Top Keywords

cherry extract
16
sweet cherry
12
prostate cells
12
glycolytic metabolism
12
hallmarks cancer
8
diminished viability
8
suppressed glycolytic
8
human prostate
8
extract
6
cells
5

Similar Publications

Unlabelled: Under-utilized fruits and vegetables are rich in nutraceuticals and have several medicinal properties. A large group of people widely consumes gummies and jelly candies, which can serve as an excellent vehicle to increase the intake of functional components. In the present study, jelly candies were developed by incorporating fruit extracts from commonly wasted segments of two under-utilized fruits (Surinam cherry and Spine gourd).

View Article and Find Full Text PDF

Earlier laboratory-based evidence has suggested that polyphenol-rich, decaffeinated whole coffee cherry extract (CCE) supports improvements in acute and long-term cognitive performance. To better understand CCE's potential to promote cognitive processing, we conducted a first-of-its-kind remote clinical trial. Participants were randomized into one of two intervention arms: placebo or 200 mg CCE.

View Article and Find Full Text PDF

Development of Imiquimod-induced HaCaT-THP-1 co-culture for modeling of psoriasis.

Eur J Pharm Sci

September 2024

Institute of Healthcare Industry, University of Debrecen, Nagyerdei körút 98., Debrecen H-4032, Hungary. Electronic address:

Psoriasis is one of the most prevalent and chronic inflammatory disease of the skin, associated with disrupted barrier function. Currently, a widely accepted, generally usable cell culture model has not been developed yet. In the present work, we aimed to establish a co-culture model with human keratinocyte (HaCaT) and human monocyte cells (THP-1) induced by Imiquimod (IMQ), which acts on the TLR7 receptor.

View Article and Find Full Text PDF

Cornelian cherry ( L.) fruits, abundant in iridoids and anthocyanins, are natural products with proven beneficial impacts on the functions of the cardiovascular system and the liver. This study aims to assess and compare whether and to what extent two different doses of resin-purified cornelian cherry extract (10 mg/kg b.

View Article and Find Full Text PDF

Although patients would rather oral therapies to injections, the gastrointestinal tract's low permeability makes this method limiting for most compounds, including anticancer drugs. Due to their low bioavailability, oral antitumor therapies suffer from significant variability in pharmacokinetics and efficacy. The improvement of their pharmacokinetic profiles can be achieved by a new approach: the use of natural extracts enriched with polyphenolic compounds that act as intestinal permeability enhancers.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!